vs
Side-by-side financial comparison of Hubbell Incorporated (HUBB) and PERRIGO Co plc (PRGO). Click either name above to swap in a different company.
Hubbell Incorporated is the larger business by last-quarter revenue ($1.5B vs $1.1B, roughly 1.3× PERRIGO Co plc). Hubbell Incorporated runs the higher net margin — 14.6% vs -127.8%, a 142.4% gap on every dollar of revenue. On growth, Hubbell Incorporated posted the faster year-over-year revenue change (11.9% vs -2.5%). Hubbell Incorporated produced more free cash flow last quarter ($388.8M vs $148.6M). Over the past eight quarters, Hubbell Incorporated's revenue compounded faster (3.3% CAGR vs 1.3%).
Hubbell Incorporated, headquartered in Shelton, Connecticut, is an American company that designs, manufactures, and sells electrical and electronic products for non-residential and residential construction, industrial, and utility applications. Hubbell was founded by Harvey Hubbell as a proprietorship in 1888, and was incorporated in Connecticut in 1905.
Perrigo Company plc is an American Irish-registered manufacturer of private label over-the-counter pharmaceuticals, and while 70% of Perrigo's net sales are from the U.S. healthcare system, Perrigo is legally headquartered in Ireland for tax purposes, which accounts for 0.60% of net sales. In 2013, Perrigo completed the sixth-largest US corporate tax inversion in history when it reregistered its tax status to Ireland to avoid U.S. corporate taxes. Perrigo maintains its corporate headquarters ...
HUBB vs PRGO — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $1.5B | $1.1B |
| Net Profit | $217.7M | $-1.4B |
| Gross Margin | 34.6% | 32.6% |
| Operating Margin | 20.3% | -116.0% |
| Net Margin | 14.6% | -127.8% |
| Revenue YoY | 11.9% | -2.5% |
| Net Profit YoY | 10.5% | -3093.9% |
| EPS (diluted) | $4.06 | $-10.23 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $1.5B | $1.1B | ||
| Q3 25 | $1.5B | $1.0B | ||
| Q2 25 | $1.5B | $1.1B | ||
| Q1 25 | $1.4B | $1.0B | ||
| Q4 24 | $1.3B | $1.1B | ||
| Q3 24 | $1.4B | $1.1B | ||
| Q2 24 | $1.5B | $1.1B | ||
| Q1 24 | $1.4B | $1.1B |
| Q4 25 | $217.7M | $-1.4B | ||
| Q3 25 | $255.5M | $7.5M | ||
| Q2 25 | $244.2M | $-8.4M | ||
| Q1 25 | $169.7M | $-6.4M | ||
| Q4 24 | $197.0M | $-44.4M | ||
| Q3 24 | $219.4M | $-21.0M | ||
| Q2 24 | $213.6M | $-108.4M | ||
| Q1 24 | $147.8M | $2.0M |
| Q4 25 | 34.6% | 32.6% | ||
| Q3 25 | 36.2% | 36.1% | ||
| Q2 25 | 37.2% | 34.4% | ||
| Q1 25 | 33.1% | 37.6% | ||
| Q4 24 | 33.8% | 33.9% | ||
| Q3 24 | 34.5% | 37.2% | ||
| Q2 24 | 35.0% | 37.0% | ||
| Q1 24 | 32.0% | 33.1% |
| Q4 25 | 20.3% | -116.0% | ||
| Q3 25 | 22.0% | 7.0% | ||
| Q2 25 | 22.7% | 4.3% | ||
| Q1 25 | 17.5% | 4.5% | ||
| Q4 24 | 19.3% | 10.0% | ||
| Q3 24 | 21.1% | 7.4% | ||
| Q2 24 | 20.7% | -2.5% | ||
| Q1 24 | 16.3% | -5.1% |
| Q4 25 | 14.6% | -127.8% | ||
| Q3 25 | 17.0% | 0.7% | ||
| Q2 25 | 16.5% | -0.8% | ||
| Q1 25 | 12.4% | -0.6% | ||
| Q4 24 | 14.8% | -3.9% | ||
| Q3 24 | 15.2% | -1.9% | ||
| Q2 24 | 14.7% | -10.2% | ||
| Q1 24 | 10.6% | 0.2% |
| Q4 25 | $4.06 | $-10.23 | ||
| Q3 25 | $4.77 | $0.05 | ||
| Q2 25 | $4.56 | $-0.06 | ||
| Q1 25 | $3.15 | $-0.05 | ||
| Q4 24 | $3.65 | $-0.32 | ||
| Q3 24 | $4.05 | $-0.15 | ||
| Q2 24 | $3.94 | $-0.79 | ||
| Q1 24 | $2.73 | $0.01 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $497.9M | — |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $3.8B | $2.9B |
| Total Assets | $8.2B | $8.5B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $497.9M | — | ||
| Q3 25 | $680.9M | $432.1M | ||
| Q2 25 | $399.6M | $454.2M | ||
| Q1 25 | $360.3M | $409.9M | ||
| Q4 24 | $345.0M | $558.8M | ||
| Q3 24 | $445.6M | $1.5B | ||
| Q2 24 | $406.5M | $542.8M | ||
| Q1 24 | $400.3M | $658.5M |
| Q4 25 | — | — | ||
| Q3 25 | $1.4B | — | ||
| Q2 25 | $1.4B | — | ||
| Q1 25 | $1.4B | — | ||
| Q4 24 | $1.4B | — | ||
| Q3 24 | $1.7B | — | ||
| Q2 24 | $1.9B | — | ||
| Q1 24 | $1.9B | — |
| Q4 25 | $3.8B | $2.9B | ||
| Q3 25 | $3.7B | $4.4B | ||
| Q2 25 | $3.5B | $4.5B | ||
| Q1 25 | $3.3B | $4.4B | ||
| Q4 24 | $3.3B | $4.3B | ||
| Q3 24 | $3.2B | $4.6B | ||
| Q2 24 | $3.1B | $4.5B | ||
| Q1 24 | $2.9B | $4.7B |
| Q4 25 | $8.2B | $8.5B | ||
| Q3 25 | $7.5B | $10.1B | ||
| Q2 25 | $7.1B | $10.1B | ||
| Q1 25 | $6.9B | $9.8B | ||
| Q4 24 | $6.7B | $9.6B | ||
| Q3 24 | $6.9B | $11.2B | ||
| Q2 24 | $6.9B | $10.4B | ||
| Q1 24 | $6.9B | $10.6B |
| Q4 25 | — | — | ||
| Q3 25 | 0.39× | — | ||
| Q2 25 | 0.41× | — | ||
| Q1 25 | 0.44× | — | ||
| Q4 24 | 0.44× | — | ||
| Q3 24 | 0.51× | — | ||
| Q2 24 | 0.63× | — | ||
| Q1 24 | 0.65× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $447.5M | $175.4M |
| Free Cash FlowOCF − Capex | $388.8M | $148.6M |
| FCF MarginFCF / Revenue | 26.0% | 13.4% |
| Capex IntensityCapex / Revenue | 3.9% | 2.4% |
| Cash ConversionOCF / Net Profit | 2.06× | — |
| TTM Free Cash FlowTrailing 4 quarters | $874.7M | $145.1M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $447.5M | $175.4M | ||
| Q3 25 | $284.3M | $51.7M | ||
| Q2 25 | $260.6M | $75.9M | ||
| Q1 25 | $37.4M | $-64.5M | ||
| Q4 24 | $432.4M | $312.6M | ||
| Q3 24 | $227.0M | $42.2M | ||
| Q2 24 | $239.6M | $9.5M | ||
| Q1 24 | $92.2M | $-1.4M |
| Q4 25 | $388.8M | $148.6M | ||
| Q3 25 | $253.8M | $29.8M | ||
| Q2 25 | $220.7M | $56.7M | ||
| Q1 25 | $11.4M | $-90.0M | ||
| Q4 24 | $364.4M | $274.9M | ||
| Q3 24 | $188.8M | $15.1M | ||
| Q2 24 | $205.7M | $-18.9M | ||
| Q1 24 | $51.9M | $-26.5M |
| Q4 25 | 26.0% | 13.4% | ||
| Q3 25 | 16.9% | 2.9% | ||
| Q2 25 | 14.9% | 5.4% | ||
| Q1 25 | 0.8% | -8.6% | ||
| Q4 24 | 27.3% | 24.2% | ||
| Q3 24 | 13.1% | 1.4% | ||
| Q2 24 | 14.2% | -1.8% | ||
| Q1 24 | 3.7% | -2.4% |
| Q4 25 | 3.9% | 2.4% | ||
| Q3 25 | 2.0% | 2.1% | ||
| Q2 25 | 2.7% | 1.8% | ||
| Q1 25 | 1.9% | 2.4% | ||
| Q4 24 | 5.1% | 3.3% | ||
| Q3 24 | 2.6% | 2.5% | ||
| Q2 24 | 2.3% | 2.7% | ||
| Q1 24 | 2.9% | 2.3% |
| Q4 25 | 2.06× | — | ||
| Q3 25 | 1.11× | 6.89× | ||
| Q2 25 | 1.07× | — | ||
| Q1 25 | 0.22× | — | ||
| Q4 24 | 2.19× | — | ||
| Q3 24 | 1.03× | — | ||
| Q2 24 | 1.12× | — | ||
| Q1 24 | 0.62× | -0.70× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
HUBB
| Grid Infrastructure | $717.0M | 48% |
| Industrial | $393.7M | 26% |
| Grid Automation | $218.9M | 15% |
| Electrical Products | $163.1M | 11% |
PRGO
| Consumer Self Care Americas | $697.0M | 63% |
| Digestive Health | $123.9M | 11% |
| Nutrition | $108.3M | 10% |
| Healthy Lifestyle | $94.8M | 9% |
| Pain And Sleep Aids | $87.1M | 8% |
